CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
| Autor: | Belogurov, Alexey, Jr. 1, 2, 3, Zakharov, Konstantin 4, Lomakin, Yakov 1, 2, Surkov, Kirill 4, Avtushenko, Sergey 4, Kruglyakov, Peter 4, Smirnov, Ivan 1, 2, Makshakov, Gleb 5, 6, Lockshin, Curtis 7, Gregoriadis, Gregory 7, Genkin, Dmitry 4, Gabibov, Alexander 1, 2, 8, Evdoshenko, Evgeniy 5, 6, 9 |
|---|---|
| Zdroj: | In Neurotherapeutics October 2016 13(4):895-904 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full text from SpringerLink